

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lymph vessel development (GO:0001945) | 5.26889565 |
| 2 | * vascular endothelial growth factor signaling pathway (GO:0038084) | 5.00663801 |
| 3 | glomerular visceral epithelial cell development (GO:0072015) | 4.99077885 |
| 4 | endothelium development (GO:0003158) | 4.65376774 |
| 5 | glomerular epithelial cell development (GO:0072310) | 4.37174372 |
| 6 | glomerular basement membrane development (GO:0032836) | 4.31677318 |
| 7 | surfactant homeostasis (GO:0043129) | 4.29216698 |
| 8 | skin morphogenesis (GO:0043589) | 4.23977501 |
| 9 | barbed-end actin filament capping (GO:0051016) | 4.13497382 |
| 10 | lymphangiogenesis (GO:0001946) | 3.85353653 |
| 11 | * retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.78387106 |
| 12 | * substrate-dependent cell migration (GO:0006929) | 3.74711755 |
| 13 | cell adhesion mediated by integrin (GO:0033627) | 3.68950762 |
| 14 | chemical homeostasis within a tissue (GO:0048875) | 3.65522663 |
| 15 | chondrocyte proliferation (GO:0035988) | 3.65201139 |
| 16 | * cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.60186228 |
| 17 | glomerular filtration (GO:0003094) | 3.48613809 |
| 18 | renal filtration (GO:0097205) | 3.47795332 |
| 19 | regulation of endothelial cell differentiation (GO:0045601) | 3.45544714 |
| 20 | basement membrane organization (GO:0071711) | 3.38104894 |
| 21 | type B pancreatic cell proliferation (GO:0044342) | 3.25700124 |
| 22 | cellular response to vitamin (GO:0071295) | 3.24975284 |
| 23 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.19825121 |
| 24 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.19793362 |
| 25 | endothelial cell morphogenesis (GO:0001886) | 3.19656085 |
| 26 | low-density lipoprotein particle clearance (GO:0034383) | 3.19547420 |
| 27 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.15805842 |
| 28 | collagen metabolic process (GO:0032963) | 3.15300676 |
| 29 | blood vessel maturation (GO:0001955) | 3.14702301 |
| 30 | cellular response to vitamin D (GO:0071305) | 3.12938593 |
| 31 | adhesion of symbiont to host cell (GO:0044650) | 3.10663622 |
| 32 | virion attachment to host cell (GO:0019062) | 3.10663622 |
| 33 | protein heterotrimerization (GO:0070208) | 3.07405725 |
| 34 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.04783431 |
| 35 | keratan sulfate catabolic process (GO:0042340) | 3.04505392 |
| 36 | apoptotic cell clearance (GO:0043277) | 3.04054626 |
| 37 | regulation of sequestering of triglyceride (GO:0010889) | 3.03495553 |
| 38 | mesodermal cell differentiation (GO:0048333) | 3.03466961 |
| 39 | collagen catabolic process (GO:0030574) | 3.01687752 |
| 40 | fatty acid transmembrane transport (GO:1902001) | 3.01382336 |
| 41 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.01284449 |
| 42 | * vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.99638023 |
| 43 | positive regulation of vasculogenesis (GO:2001214) | 2.96597488 |
| 44 | glomerulus development (GO:0032835) | 2.95844523 |
| 45 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.95428162 |
| 46 | regulation of cholesterol storage (GO:0010885) | 2.93419308 |
| 47 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.91174478 |
| 48 | plasma membrane repair (GO:0001778) | 2.90616955 |
| 49 | regulation of mononuclear cell migration (GO:0071675) | 2.90011713 |
| 50 | * patterning of blood vessels (GO:0001569) | 2.89989495 |
| 51 | * cell migration involved in sprouting angiogenesis (GO:0002042) | 2.87551624 |
| 52 | kidney mesenchyme development (GO:0072074) | 2.82978169 |
| 53 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.82925866 |
| 54 | membrane raft organization (GO:0031579) | 2.82844712 |
| 55 | negative regulation of anoikis (GO:2000811) | 2.82838572 |
| 56 | Golgi transport vesicle coating (GO:0048200) | 2.82477056 |
| 57 | COPI coating of Golgi vesicle (GO:0048205) | 2.82477056 |
| 58 | regulation of vasculogenesis (GO:2001212) | 2.82408804 |
| 59 | negative regulation of fibrinolysis (GO:0051918) | 2.81931637 |
| 60 | venous blood vessel morphogenesis (GO:0048845) | 2.81639035 |
| 61 | wound healing, spreading of cells (GO:0044319) | 2.79368697 |
| 62 | transcytosis (GO:0045056) | 2.78758643 |
| 63 | adhesion of symbiont to host (GO:0044406) | 2.78450915 |
| 64 | hemidesmosome assembly (GO:0031581) | 2.77907543 |
| 65 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.77647762 |
| 66 | extracellular matrix disassembly (GO:0022617) | 2.76865939 |
| 67 | multicellular organismal metabolic process (GO:0044236) | 2.76753795 |
| 68 | muscle cell migration (GO:0014812) | 2.74752836 |
| 69 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.74735566 |
| 70 | multicellular organismal catabolic process (GO:0044243) | 2.73510471 |
| 71 | metanephric mesenchyme development (GO:0072075) | 2.72584882 |
| 72 | epithelial cell-cell adhesion (GO:0090136) | 2.72152574 |
| 73 | heart trabecula formation (GO:0060347) | 2.72005947 |
| 74 | Notch signaling involved in heart development (GO:0061314) | 2.70924651 |
| 75 | blood vessel remodeling (GO:0001974) | 2.70329638 |
| 76 | extracellular fibril organization (GO:0043206) | 2.69218641 |
| 77 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.68831232 |
| 78 | hyaluronan catabolic process (GO:0030214) | 2.67925905 |
| 79 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.67366391 |
| 80 | complement activation, alternative pathway (GO:0006957) | 2.67125181 |
| 81 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.66621019 |
| 82 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.65716203 |
| 83 | positive regulation of p38MAPK cascade (GO:1900745) | 2.63993528 |
| 84 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.63862165 |
| 85 | cardiac myofibril assembly (GO:0055003) | 2.63850852 |
| 86 | stress fiber assembly (GO:0043149) | 2.63570202 |
| 87 | * blood vessel endothelial cell migration (GO:0043534) | 2.63383783 |
| 88 | extracellular regulation of signal transduction (GO:1900115) | 2.62211307 |
| 89 | extracellular negative regulation of signal transduction (GO:1900116) | 2.62211307 |
| 90 | wound healing, spreading of epidermal cells (GO:0035313) | 2.59946573 |
| 91 | positive regulation of fatty acid oxidation (GO:0046321) | 2.59944111 |
| 92 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.59125278 |
| 93 | negative regulation of adherens junction organization (GO:1903392) | 2.58094548 |
| 94 | negative regulation of focal adhesion assembly (GO:0051895) | 2.58094548 |
| 95 | negative regulation of cell junction assembly (GO:1901889) | 2.58094548 |
| 96 | * axon extension involved in axon guidance (GO:0048846) | 2.58043424 |
| 97 | * neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.58043424 |
| 98 | protein hydroxylation (GO:0018126) | 2.57845774 |
| 99 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.57443756 |
| 100 | iron ion import (GO:0097286) | 2.57098160 |
| 101 | positive regulation of receptor recycling (GO:0001921) | 2.56057666 |
| 102 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.55226971 |
| 103 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.54411297 |
| 104 | extracellular matrix assembly (GO:0085029) | 2.54385809 |
| 105 | hypotonic response (GO:0006971) | 2.54295896 |
| 106 | * sprouting angiogenesis (GO:0002040) | 2.53555468 |
| 107 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.53390166 |
| 108 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.53231323 |
| 109 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.52768956 |
| 110 | phagocytosis, recognition (GO:0006910) | 2.52089963 |
| 111 | glial cell migration (GO:0008347) | 2.51952823 |
| 112 | protein carboxylation (GO:0018214) | 2.51580794 |
| 113 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.51580794 |
| 114 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.50778889 |
| 115 | endothelial cell proliferation (GO:0001935) | 2.50304708 |
| 116 | regulation of fibrinolysis (GO:0051917) | 2.50124808 |
| 117 | cell-substrate junction assembly (GO:0007044) | 2.50053454 |
| 118 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 2.49157590 |
| 119 | fibril organization (GO:0097435) | 2.48050178 |
| 120 | positive regulation of hemostasis (GO:1900048) | 2.46940199 |
| 121 | positive regulation of blood coagulation (GO:0030194) | 2.46940199 |
| 122 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.46422860 |
| 123 | cGMP-mediated signaling (GO:0019934) | 2.45282995 |
| 124 | lung vasculature development (GO:0060426) | 2.45061158 |
| 125 | * dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.44766701 |
| 126 | extracellular matrix organization (GO:0030198) | 2.43887335 |
| 127 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.43620842 |
| 128 | response to magnesium ion (GO:0032026) | 2.43130588 |
| 129 | positive regulation of cell junction assembly (GO:1901890) | 2.43000616 |
| 130 | positive regulation of focal adhesion assembly (GO:0051894) | 2.43000616 |
| 131 | extracellular structure organization (GO:0043062) | 2.42854538 |
| 132 | morphogenesis of an endothelium (GO:0003159) | 2.42677482 |
| 133 | endothelial tube morphogenesis (GO:0061154) | 2.42677482 |
| 134 | negative regulation of platelet activation (GO:0010544) | 2.42662169 |
| 135 | * positive regulation of epithelial cell migration (GO:0010634) | 2.42350315 |
| 136 | regulation of protein activation cascade (GO:2000257) | 2.42169884 |
| 137 | positive regulation of extracellular matrix organization (GO:1903055) | 2.42143758 |
| 138 | regulation of tight junction assembly (GO:2000810) | 2.42096572 |
| 139 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.41532522 |
| 140 | ovulation from ovarian follicle (GO:0001542) | 2.41263717 |
| 141 | regulation of complement activation (GO:0030449) | 2.40611191 |
| 142 | cell migration involved in heart development (GO:0060973) | 2.37582718 |
| 143 | endothelial cell differentiation (GO:0045446) | 2.37301036 |
| 144 | positive regulation of adherens junction organization (GO:1903393) | 2.36066291 |
| 145 | plasma lipoprotein particle clearance (GO:0034381) | 2.35905215 |
| 146 | negative regulation of blood coagulation (GO:0030195) | 2.35643570 |
| 147 | negative regulation of hemostasis (GO:1900047) | 2.35643570 |
| 148 | negative regulation of endothelial cell migration (GO:0010596) | 2.35464575 |
| 149 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 2.33547065 |
| 150 | regulation of p38MAPK cascade (GO:1900744) | 2.33392631 |
| 151 | response to fluid shear stress (GO:0034405) | 2.31789862 |
| 152 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.31221337 |
| 153 | fibrinolysis (GO:0042730) | 2.31202142 |
| 154 | smooth muscle tissue development (GO:0048745) | 2.30913902 |
| 155 | vasculogenesis (GO:0001570) | 2.28093876 |
| 156 | carnitine shuttle (GO:0006853) | 2.27987355 |
| 157 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.27813866 |
| 158 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.27728668 |
| 159 | positive regulation of macrophage cytokine production (GO:0060907) | 2.27464645 |
| 160 | * endothelial cell migration (GO:0043542) | 2.26269760 |
| 161 | positive regulation of coagulation (GO:0050820) | 2.25355757 |
| 162 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.24771564 |
| 163 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.22746692 |
| 164 | collagen fibril organization (GO:0030199) | 2.22183322 |
| 165 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.21784405 |
| 166 | endodermal cell differentiation (GO:0035987) | 2.20901874 |
| 167 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.20613338 |
| 168 | alpha-linolenic acid metabolic process (GO:0036109) | 2.20427179 |
| 169 | negative regulation of coagulation (GO:0050819) | 2.20247200 |
| 170 | positive regulation of lipid storage (GO:0010884) | 2.18876217 |
| 171 | * blood vessel morphogenesis (GO:0048514) | 2.17978866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.88211939 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.54983855 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.97105759 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.77383463 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.54934538 |
| 6 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.34659855 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.26199051 |
| 8 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.23212586 |
| 9 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.23085384 |
| 10 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.22117008 |
| 11 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.21508798 |
| 12 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.18909051 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.12125402 |
| 14 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.07034221 |
| 15 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.99354611 |
| 16 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.91057960 |
| 17 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.89504170 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.83289114 |
| 19 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.81576368 |
| 20 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.80202821 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74777878 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.68016312 |
| 23 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.67227347 |
| 24 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.62938857 |
| 25 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.62511005 |
| 26 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.61630957 |
| 27 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.61028701 |
| 28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.60495990 |
| 29 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.59933788 |
| 30 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.59933788 |
| 31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58995907 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.56219954 |
| 33 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.56107526 |
| 34 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.55642442 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55569992 |
| 36 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.53918885 |
| 37 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52651799 |
| 38 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.50501279 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49417741 |
| 40 | * FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.48139334 |
| 41 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.45880679 |
| 42 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.45126082 |
| 43 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.43846520 |
| 44 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.42908350 |
| 45 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.42908350 |
| 46 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.41327610 |
| 47 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40512800 |
| 48 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.40230044 |
| 49 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39513017 |
| 50 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.37707230 |
| 51 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.37550923 |
| 52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.36364924 |
| 53 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.36129569 |
| 54 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.36129569 |
| 55 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35163450 |
| 56 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.32253769 |
| 57 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.32140270 |
| 58 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.31449998 |
| 59 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.30931670 |
| 60 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.28883622 |
| 61 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28724652 |
| 62 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.27471270 |
| 63 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27456661 |
| 64 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26684716 |
| 65 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26621838 |
| 66 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.24237513 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23736377 |
| 68 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.22583774 |
| 69 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.21342318 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.20556499 |
| 71 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.20266183 |
| 72 | * GBX2_23144817_ChIP-Seq_PC3_Human | 1.19742612 |
| 73 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19475148 |
| 74 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.19183946 |
| 75 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.18054638 |
| 76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16812260 |
| 77 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.13708314 |
| 78 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12378519 |
| 79 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.12001622 |
| 80 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08898953 |
| 81 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06913150 |
| 82 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.05185970 |
| 83 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.05131934 |
| 84 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03136571 |
| 85 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.03061379 |
| 86 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02992446 |
| 87 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02788187 |
| 88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.02684536 |
| 89 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.02668420 |
| 90 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02644053 |
| 91 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.02348691 |
| 92 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01676043 |
| 93 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.01626383 |
| 94 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01214151 |
| 95 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.00783778 |
| 96 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99895755 |
| 97 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99667457 |
| 98 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99410358 |
| 99 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.99184810 |
| 100 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.98390836 |
| 101 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.98371712 |
| 102 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.98271696 |
| 103 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98031657 |
| 104 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97808927 |
| 105 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.97216975 |
| 106 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.97185882 |
| 107 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.96826752 |
| 108 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96365109 |
| 109 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96290771 |
| 110 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95757532 |
| 111 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.94277729 |
| 112 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94276601 |
| 113 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94269011 |
| 114 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93780024 |
| 115 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92953799 |
| 116 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92581487 |
| 117 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.92491603 |
| 118 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91650721 |
| 119 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91577584 |
| 120 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91477855 |
| 121 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90893645 |
| 122 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.90845947 |
| 123 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.90845947 |
| 124 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.90618360 |
| 125 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.90574914 |
| 126 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.89870139 |
| 127 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89291215 |
| 128 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.88572949 |
| 129 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88112630 |
| 130 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.88092259 |
| 131 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87384957 |
| 132 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.86900206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010368_abnormal_lymphatic_system | 5.04913501 |
| 2 | MP0004272_abnormal_basement_membrane | 4.15105995 |
| 3 | MP0001879_abnormal_lymphatic_vessel | 4.13143653 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.85253865 |
| 5 | MP0003279_aneurysm | 2.92054393 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 2.88255651 |
| 7 | MP0005167_abnormal_blood-brain_barrier | 2.85893680 |
| 8 | MP0004084_abnormal_cardiac_muscle | 2.67403830 |
| 9 | MP0005257_abnormal_intraocular_pressure | 2.51905134 |
| 10 | MP0003828_pulmonary_edema | 2.50630146 |
| 11 | MP0001958_emphysema | 2.38724952 |
| 12 | MP0005360_urolithiasis | 2.25291900 |
| 13 | MP0003724_increased_susceptibility_to | 2.24429217 |
| 14 | MP0005275_abnormal_skin_tensile | 2.18028700 |
| 15 | MP0004130_abnormal_muscle_cell | 2.14511010 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 2.09059114 |
| 17 | MP0006138_congestive_heart_failure | 2.04387559 |
| 18 | MP0005623_abnormal_meninges_morphology | 1.94242800 |
| 19 | MP0003566_abnormal_cell_adhesion | 1.93155958 |
| 20 | MP0000767_abnormal_smooth_muscle | 1.90658120 |
| 21 | MP0002295_abnormal_pulmonary_circulatio | 1.88667905 |
| 22 | MP0001542_abnormal_bone_strength | 1.86628957 |
| 23 | MP0002139_abnormal_hepatobiliary_system | 1.74897760 |
| 24 | MP0000751_myopathy | 1.71676009 |
| 25 | MP0000343_altered_response_to | 1.67725923 |
| 26 | MP0005670_abnormal_white_adipose | 1.65468694 |
| 27 | MP0005385_cardiovascular_system_phenoty | 1.64461383 |
| 28 | MP0001544_abnormal_cardiovascular_syste | 1.64461383 |
| 29 | MP0004036_abnormal_muscle_relaxation | 1.63654185 |
| 30 | MP0005503_abnormal_tendon_morphology | 1.62865258 |
| 31 | MP0002972_abnormal_cardiac_muscle | 1.59521730 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.59346537 |
| 33 | MP0003252_abnormal_bile_duct | 1.58972883 |
| 34 | MP0003191_abnormal_cellular_cholesterol | 1.57917504 |
| 35 | MP0005365_abnormal_bile_salt | 1.55620962 |
| 36 | MP0005085_abnormal_gallbladder_physiolo | 1.54533723 |
| 37 | MP0005330_cardiomyopathy | 1.50887562 |
| 38 | MP0005165_increased_susceptibility_to | 1.49465156 |
| 39 | MP0003091_abnormal_cell_migration | 1.49111730 |
| 40 | MP0004215_abnormal_myocardial_fiber | 1.47904995 |
| 41 | MP0004484_altered_response_of | 1.47903852 |
| 42 | MP0009384_cardiac_valve_regurgitation | 1.47860681 |
| 43 | MP0000733_abnormal_muscle_development | 1.44477879 |
| 44 | MP0005595_abnormal_vascular_smooth | 1.42916633 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.40150277 |
| 46 | * MP0002128_abnormal_blood_circulation | 1.37793850 |
| 47 | MP0008775_abnormal_heart_ventricle | 1.35632344 |
| 48 | MP0002138_abnormal_hepatobiliary_system | 1.35421505 |
| 49 | MP0010630_abnormal_cardiac_muscle | 1.34511037 |
| 50 | MP0010386_abnormal_urinary_bladder | 1.34263861 |
| 51 | MP0000249_abnormal_blood_vessel | 1.33090812 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.32592614 |
| 53 | MP0001299_abnormal_eye_distance/ | 1.32185065 |
| 54 | MP0010329_abnormal_lipoprotein_level | 1.30886700 |
| 55 | MP0005508_abnormal_skeleton_morphology | 1.29996081 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.29501988 |
| 57 | MP0002332_abnormal_exercise_endurance | 1.29235590 |
| 58 | MP0005620_abnormal_muscle_contractility | 1.28676727 |
| 59 | MP0005666_abnormal_adipose_tissue | 1.22115346 |
| 60 | MP0002060_abnormal_skin_morphology | 1.20143078 |
| 61 | MP0000604_amyloidosis | 1.19236213 |
| 62 | MP0005197_abnormal_uvea_morphology | 1.18704902 |
| 63 | MP0005164_abnormal_response_to | 1.18252289 |
| 64 | MP0004087_abnormal_muscle_fiber | 1.15473192 |
| 65 | MP0004233_abnormal_muscle_weight | 1.15342865 |
| 66 | MP0000230_abnormal_systemic_arterial | 1.14351465 |
| 67 | MP0009053_abnormal_anal_canal | 1.13397784 |
| 68 | * MP0001614_abnormal_blood_vessel | 1.10969835 |
| 69 | MP0006054_spinal_hemorrhage | 1.10638556 |
| 70 | MP0009780_abnormal_chondrocyte_physiolo | 1.10582746 |
| 71 | MP0004883_abnormal_blood_vessel | 1.10311960 |
| 72 | MP0003303_peritoneal_inflammation | 1.10001753 |
| 73 | MP0004858_abnormal_nervous_system | 1.08809703 |
| 74 | MP0000537_abnormal_urethra_morphology | 1.08802145 |
| 75 | MP0000534_abnormal_ureter_morphology | 1.07723231 |
| 76 | MP0004085_abnormal_heartbeat | 1.05992351 |
| 77 | MP0001243_abnormal_dermal_layer | 1.04965373 |
| 78 | MP0004510_myositis | 1.04509060 |
| 79 | MP0005388_respiratory_system_phenotype | 1.02904555 |
| 80 | MP0002133_abnormal_respiratory_system | 1.02904555 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 1.02656143 |
| 82 | MP0003329_amyloid_beta_deposits | 0.99466698 |
| 83 | MP0000749_muscle_degeneration | 0.98460708 |
| 84 | MP0008875_abnormal_xenobiotic_pharmacok | 0.98167134 |
| 85 | MP0000750_abnormal_muscle_regeneration | 0.95388361 |
| 86 | MP0005332_abnormal_amino_acid | 0.94026446 |
| 87 | MP0009840_abnormal_foam_cell | 0.93407128 |
| 88 | MP0001849_ear_inflammation | 0.93112249 |
| 89 | * MP0002925_abnormal_cardiovascular_devel | 0.92517172 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 0.92515025 |
| 91 | MP0005058_abnormal_lysosome_morphology | 0.92416765 |
| 92 | MP0000759_abnormal_skeletal_muscle | 0.90847041 |
| 93 | MP0010030_abnormal_orbit_morphology | 0.90057446 |
| 94 | MP0005375_adipose_tissue_phenotype | 0.89434488 |
| 95 | MP0003690_abnormal_glial_cell | 0.89199321 |
| 96 | MP0003950_abnormal_plasma_membrane | 0.87768188 |
| 97 | MP0003075_altered_response_to | 0.87540353 |
| 98 | MP0003448_altered_tumor_morphology | 0.87245757 |
| 99 | MP0005083_abnormal_biliary_tract | 0.86948358 |
| 100 | MP0005390_skeleton_phenotype | 0.86901144 |
| 101 | MP0001533_abnormal_skeleton_physiology | 0.86625817 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.86364082 |
| 103 | MP0001756_abnormal_urination | 0.85999333 |
| 104 | MP0009697_abnormal_copulation | 0.84963623 |
| 105 | MP0003045_fibrosis | 0.84167376 |
| 106 | * MP0000266_abnormal_heart_morphology | 0.82675585 |
| 107 | MP0000747_muscle_weakness | 0.82065196 |
| 108 | MP0001915_intracranial_hemorrhage | 0.81575783 |
| 109 | MP0002896_abnormal_bone_mineralization | 0.81213068 |
| 110 | MP0009764_decreased_sensitivity_to | 0.80764234 |
| 111 | MP0005193_abnormal_anterior_eye | 0.79578104 |
| 112 | MP0005023_abnormal_wound_healing | 0.78690538 |
| 113 | MP0002118_abnormal_lipid_homeostasis | 0.77885140 |
| 114 | MP0002933_joint_inflammation | 0.75824715 |
| 115 | MP0009643_abnormal_urine_homeostasis | 0.74890367 |
| 116 | MP0002971_abnormal_brown_adipose | 0.74637966 |
| 117 | MP0002108_abnormal_muscle_morphology | 0.74184926 |
| 118 | * MP0002127_abnormal_cardiovascular_syste | 0.73930903 |
| 119 | MP0002168_other_aberrant_phenotype | 0.73915685 |
| 120 | MP0009250_abnormal_appendicular_skeleto | 0.73720171 |
| 121 | MP0000003_abnormal_adipose_tissue | 0.73220823 |
| 122 | MP0000609_abnormal_liver_physiology | 0.72907484 |
| 123 | MP0000163_abnormal_cartilage_morphology | 0.72593570 |
| 124 | MP0001175_abnormal_lung_morphology | 0.71490667 |
| 125 | MP0005319_abnormal_enzyme/_coenzyme | 0.71460484 |
| 126 | MP0008004_abnormal_stomach_pH | 0.70543793 |
| 127 | MP0003137_abnormal_impulse_conducting | 0.69635094 |
| 128 | MP0002136_abnormal_kidney_physiology | 0.69529248 |
| 129 | MP0002113_abnormal_skeleton_development | 0.68347930 |
| 130 | MP0005171_absent_coat_pigmentation | 0.68070730 |
| 131 | MP0002135_abnormal_kidney_morphology | 0.67858057 |
| 132 | MP0005409_darkened_coat_color | 0.65458313 |
| 133 | MP0002282_abnormal_trachea_morphology | 0.64034821 |
| 134 | MP0002115_abnormal_skeleton_extremities | 0.63330932 |
| 135 | MP0003385_abnormal_body_wall | 0.62859251 |
| 136 | MP0003795_abnormal_bone_structure | 0.62122036 |
| 137 | MP0003941_abnormal_skin_development | 0.62054573 |
| 138 | MP0006082_CNS_inflammation | 0.61497503 |
| 139 | MP0003634_abnormal_glial_cell | 0.61020200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hematochezia (HP:0002573) | 4.01389047 |
| 2 | Cervical subluxation (HP:0003308) | 3.98449275 |
| 3 | Deep venous thrombosis (HP:0002625) | 3.96443987 |
| 4 | Polycythemia (HP:0001901) | 3.86350197 |
| 5 | Cerebral aneurysm (HP:0004944) | 3.81040850 |
| 6 | Broad metatarsal (HP:0001783) | 3.73548149 |
| 7 | Spontaneous hematomas (HP:0007420) | 3.70762827 |
| 8 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.60161136 |
| 9 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.60161136 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 3.60161136 |
| 11 | Complement deficiency (HP:0004431) | 3.55749911 |
| 12 | Protrusio acetabuli (HP:0003179) | 3.51420942 |
| 13 | Esophageal varix (HP:0002040) | 3.44232668 |
| 14 | Vertebral compression fractures (HP:0002953) | 3.38314697 |
| 15 | Aortic aneurysm (HP:0004942) | 3.37379225 |
| 16 | Lymphangioma (HP:0100764) | 3.33690571 |
| 17 | Premature rupture of membranes (HP:0001788) | 3.31819206 |
| 18 | Nephritis (HP:0000123) | 3.26463371 |
| 19 | Aortic dissection (HP:0002647) | 3.22040344 |
| 20 | Spondylolisthesis (HP:0003302) | 3.20742459 |
| 21 | Glomerulonephritis (HP:0000099) | 3.17808515 |
| 22 | Increased connective tissue (HP:0009025) | 3.15161616 |
| 23 | Short nail (HP:0001799) | 3.10841141 |
| 24 | Follicular hyperkeratosis (HP:0007502) | 3.06064684 |
| 25 | Wormian bones (HP:0002645) | 3.03874130 |
| 26 | Systemic lupus erythematosus (HP:0002725) | 2.90118676 |
| 27 | Conjunctival telangiectasia (HP:0000524) | 2.78552410 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 2.76809880 |
| 29 | Abnormality of complement system (HP:0005339) | 2.76692878 |
| 30 | Sudden death (HP:0001699) | 2.74380677 |
| 31 | Neurofibrillary tangles (HP:0002185) | 2.73793595 |
| 32 | Myocardial infarction (HP:0001658) | 2.72826847 |
| 33 | Vascular tortuosity (HP:0004948) | 2.70036586 |
| 34 | Joint hemorrhage (HP:0005261) | 2.63398857 |
| 35 | Arterial tortuosity (HP:0005116) | 2.62728476 |
| 36 | Muscle fiber splitting (HP:0003555) | 2.60891981 |
| 37 | Mesangial abnormality (HP:0001966) | 2.60219435 |
| 38 | Focal segmental glomerulosclerosis (HP:0000097) | 2.59624920 |
| 39 | Visceral angiomatosis (HP:0100761) | 2.59037383 |
| 40 | Aneurysm (HP:0002617) | 2.58757915 |
| 41 | Hemangiomatosis (HP:0007461) | 2.58722702 |
| 42 | Fragile skin (HP:0001030) | 2.58105967 |
| 43 | Mitral valve prolapse (HP:0001634) | 2.52922750 |
| 44 | Cerebral hemorrhage (HP:0001342) | 2.50093431 |
| 45 | Shallow orbits (HP:0000586) | 2.49366297 |
| 46 | Xanthomatosis (HP:0000991) | 2.47832032 |
| 47 | Atrial fibrillation (HP:0005110) | 2.46912457 |
| 48 | Dysostosis multiplex (HP:0000943) | 2.44291959 |
| 49 | Ventricular tachycardia (HP:0004756) | 2.41363326 |
| 50 | Nuclear cataract (HP:0100018) | 2.40239354 |
| 51 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.39970672 |
| 52 | Venous insufficiency (HP:0005293) | 2.35689520 |
| 53 | Mucosal telangiectasiae (HP:0100579) | 2.35300066 |
| 54 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.35280355 |
| 55 | Bone cyst (HP:0012062) | 2.35073423 |
| 56 | Primary atrial arrhythmia (HP:0001692) | 2.34888005 |
| 57 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.34455357 |
| 58 | Right ventricular cardiomyopathy (HP:0011663) | 2.32068630 |
| 59 | Abnormality of dentin (HP:0010299) | 2.31643506 |
| 60 | Venous abnormality (HP:0002624) | 2.31598631 |
| 61 | Supraventricular arrhythmia (HP:0005115) | 2.30042539 |
| 62 | Hyperlipoproteinemia (HP:0010980) | 2.29508291 |
| 63 | Camptodactyly of toe (HP:0001836) | 2.28685777 |
| 64 | Mucopolysacchariduria (HP:0008155) | 2.25909793 |
| 65 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25909793 |
| 66 | Cardiovascular calcification (HP:0011915) | 2.25779263 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.24522092 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.24522092 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.24522092 |
| 70 | Lipoatrophy (HP:0100578) | 2.24345704 |
| 71 | Slender build (HP:0001533) | 2.24102773 |
| 72 | Genu recurvatum (HP:0002816) | 2.23604571 |
| 73 | Tetraparesis (HP:0002273) | 2.23030160 |
| 74 | Ankle contracture (HP:0006466) | 2.19997264 |
| 75 | Hyporeflexia of lower limbs (HP:0002600) | 2.19877774 |
| 76 | Skin nodule (HP:0200036) | 2.19733680 |
| 77 | Aortic regurgitation (HP:0001659) | 2.18388526 |
| 78 | Neonatal short-limb short stature (HP:0008921) | 2.17377236 |
| 79 | Cavernous hemangioma (HP:0001048) | 2.17217039 |
| 80 | Vacuolated lymphocytes (HP:0001922) | 2.16333532 |
| 81 | Asymmetric septal hypertrophy (HP:0001670) | 2.15554243 |
| 82 | Absent frontal sinuses (HP:0002688) | 2.14271148 |
| 83 | Increased variability in muscle fiber diameter (HP:0003557) | 2.13186376 |
| 84 | Supraventricular tachycardia (HP:0004755) | 2.13147418 |
| 85 | Distal lower limb amyotrophy (HP:0008944) | 2.09553682 |
| 86 | Hemorrhage of the eye (HP:0011885) | 2.09303967 |
| 87 | Joint laxity (HP:0001388) | 2.09282509 |
| 88 | Mitral stenosis (HP:0001718) | 2.08341897 |
| 89 | Cerebral inclusion bodies (HP:0100314) | 2.07684921 |
| 90 | Hypoglycemic coma (HP:0001325) | 2.07143395 |
| 91 | Joint stiffness (HP:0001387) | 2.05395787 |
| 92 | Abnormality of the acetabulum (HP:0003170) | 2.05060584 |
| 93 | Peritonitis (HP:0002586) | 2.04584027 |
| 94 | Mitral regurgitation (HP:0001653) | 2.04223073 |
| 95 | Chondrocalcinosis (HP:0000934) | 2.03435948 |
| 96 | Aortic valve stenosis (HP:0001650) | 2.03084118 |
| 97 | Ovoid vertebral bodies (HP:0003300) | 2.01997052 |
| 98 | Glomerulosclerosis (HP:0000096) | 2.01963768 |
| 99 | Abnormality of the common coagulation pathway (HP:0010990) | 2.01290092 |
| 100 | Long toe (HP:0010511) | 2.01061446 |
| 101 | Hypoplasia of the iris (HP:0007676) | 2.00081005 |
| 102 | Elbow flexion contracture (HP:0002987) | 1.99904947 |
| 103 | Abnormality of the ischium (HP:0003174) | 1.99721383 |
| 104 | Spinal rigidity (HP:0003306) | 1.97711537 |
| 105 | Difficulty running (HP:0009046) | 1.97428368 |
| 106 | Short hallux (HP:0010109) | 1.96977802 |
| 107 | Wrist flexion contracture (HP:0001239) | 1.96877605 |
| 108 | Axonal loss (HP:0003447) | 1.96441757 |
| 109 | Hypoplastic ischia (HP:0003175) | 1.95802462 |
| 110 | Potter facies (HP:0002009) | 1.94909246 |
| 111 | Facial shape deformation (HP:0011334) | 1.94909246 |
| 112 | Difficulty climbing stairs (HP:0003551) | 1.94832155 |
| 113 | Overgrowth (HP:0001548) | 1.93674482 |
| 114 | Dilatation of the ascending aorta (HP:0005111) | 1.93650775 |
| 115 | Pulmonary hypertension (HP:0002092) | 1.93316543 |
| 116 | Striae distensae (HP:0001065) | 1.92960496 |
| 117 | Abnormality of Sharpey fibers (HP:0100685) | 1.92840987 |
| 118 | Ectopia lentis (HP:0001083) | 1.92021557 |
| 119 | Abnormality of carpal bone ossification (HP:0006257) | 1.91457498 |
| 120 | Vascular calcification (HP:0004934) | 1.90568691 |
| 121 | Distal lower limb muscle weakness (HP:0009053) | 1.89643111 |
| 122 | Natal tooth (HP:0000695) | 1.89103878 |
| 123 | Pulmonary artery stenosis (HP:0004415) | 1.88486043 |
| 124 | Disproportionate tall stature (HP:0001519) | 1.87642380 |
| 125 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.87058379 |
| 126 | Spinal cord lesions (HP:0100561) | 1.85723834 |
| 127 | Syringomyelia (HP:0003396) | 1.85723834 |
| 128 | Nonimmune hydrops fetalis (HP:0001790) | 1.84977217 |
| 129 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.82474203 |
| 130 | Distal upper limb amyotrophy (HP:0007149) | 1.82411326 |
| 131 | Upper limb amyotrophy (HP:0009129) | 1.82411326 |
| 132 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.80954725 |
| 133 | Atrophic scars (HP:0001075) | 1.80658909 |
| 134 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.80192826 |
| 135 | Hyperextensible skin (HP:0000974) | 1.79941552 |
| 136 | Portal hypertension (HP:0001409) | 1.79612809 |
| 137 | Abnormal ossification of hand bones (HP:0005921) | 1.79605356 |
| 138 | Hypercholesterolemia (HP:0003124) | 1.79479042 |
| 139 | Broad face (HP:0000283) | 1.78905950 |
| 140 | Flexion contracture of toe (HP:0005830) | 1.78345402 |
| 141 | Joint contractures involving the joints of the feet (HP:0100492) | 1.78345402 |
| 142 | Tibial bowing (HP:0002982) | 1.77961225 |
| 143 | Limb-girdle muscle atrophy (HP:0003797) | 1.77226417 |
| 144 | Blue sclerae (HP:0000592) | 1.76317711 |
| 145 | Exotropia (HP:0000577) | 1.76040094 |
| 146 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.75831077 |
| 147 | Bladder diverticulum (HP:0000015) | 1.75805262 |
| 148 | Soft skin (HP:0000977) | 1.74895101 |
| 149 | Lower limb amyotrophy (HP:0007210) | 1.74762516 |
| 150 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.74602537 |
| 151 | Osteolytic defects of the hand bones (HP:0009699) | 1.74602537 |
| 152 | Stroke (HP:0001297) | 1.74464031 |
| 153 | Type 1 muscle fiber predominance (HP:0003803) | 1.74104108 |
| 154 | Generalized amyotrophy (HP:0003700) | 1.73755251 |
| 155 | Bradycardia (HP:0001662) | 1.73740037 |
| 156 | Interstitial pulmonary disease (HP:0006530) | 1.73606719 |
| 157 | Hypolipoproteinemia (HP:0010981) | 1.73070512 |
| 158 | Wide anterior fontanel (HP:0000260) | 1.71501263 |
| 159 | Coxa vara (HP:0002812) | 1.71189483 |
| 160 | Flared iliac wings (HP:0002869) | 1.68716837 |
| 161 | Upper motor neuron abnormality (HP:0002127) | 1.67364005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 6.94953479 |
| 2 | KDR | 4.51842210 |
| 3 | TGFBR2 | 4.28400469 |
| 4 | MST1R | 3.13071506 |
| 5 | INSRR | 2.58547279 |
| 6 | TTN | 2.57792384 |
| 7 | LIMK1 | 2.56352742 |
| 8 | TRIB3 | 2.56213949 |
| 9 | EPHB2 | 2.46275491 |
| 10 | EPHA2 | 2.38941505 |
| 11 | IRAK3 | 2.38760148 |
| 12 | MOS | 2.33132860 |
| 13 | MYLK | 2.29668903 |
| 14 | ERBB4 | 2.21917721 |
| 15 | TESK1 | 2.10425308 |
| 16 | PDGFRA | 2.00405019 |
| 17 | PTK2B | 1.89477539 |
| 18 | AKT3 | 1.89192703 |
| 19 | RIPK1 | 1.84571951 |
| 20 | TGFBR1 | 1.66792544 |
| 21 | ERN1 | 1.58875820 |
| 22 | EPHA3 | 1.58063176 |
| 23 | CAMK1D | 1.50584819 |
| 24 | PKN2 | 1.49759210 |
| 25 | DMPK | 1.46448274 |
| 26 | FGFR4 | 1.41829155 |
| 27 | FER | 1.35382833 |
| 28 | PTK6 | 1.32367313 |
| 29 | NEK9 | 1.30952450 |
| 30 | WNK4 | 1.28652008 |
| 31 | LATS1 | 1.26310442 |
| 32 | ICK | 1.23645696 |
| 33 | CAMK1G | 1.18818676 |
| 34 | FGFR3 | 1.18537005 |
| 35 | STK38 | 1.06952248 |
| 36 | PDK2 | 1.04550016 |
| 37 | NME2 | 1.01594116 |
| 38 | MAPK12 | 1.01548068 |
| 39 | JAK1 | 1.00876131 |
| 40 | SIK1 | 0.99510229 |
| 41 | PDGFRB | 0.98339670 |
| 42 | PIK3CA | 0.98010828 |
| 43 | ROCK2 | 0.96811349 |
| 44 | PAK6 | 0.94593246 |
| 45 | CDC42BPA | 0.93599515 |
| 46 | GRK7 | 0.93333837 |
| 47 | BCR | 0.92586198 |
| 48 | MAP2K3 | 0.91643346 |
| 49 | PRKD1 | 0.91523774 |
| 50 | OBSCN | 0.91375098 |
| 51 | PRKAA2 | 0.91051229 |
| 52 | CAMKK2 | 0.90608655 |
| 53 | FGFR2 | 0.89013893 |
| 54 | PRKCH | 0.88783642 |
| 55 | IGF1R | 0.84422183 |
| 56 | TYK2 | 0.84142813 |
| 57 | MAP3K6 | 0.82279440 |
| 58 | LMTK2 | 0.81818055 |
| 59 | MAP3K3 | 0.81762893 |
| 60 | PTK2 | 0.80189496 |
| 61 | SCYL2 | 0.80179219 |
| 62 | FRK | 0.79212371 |
| 63 | KIT | 0.78929250 |
| 64 | MAP3K7 | 0.77231463 |
| 65 | NUAK1 | 0.76836516 |
| 66 | PHKG1 | 0.76687806 |
| 67 | PHKG2 | 0.76687806 |
| 68 | TRPM7 | 0.73390614 |
| 69 | ROCK1 | 0.70426522 |
| 70 | DDR2 | 0.69438919 |
| 71 | KSR1 | 0.69406690 |
| 72 | GSK3A | 0.69082301 |
| 73 | PAK3 | 0.68770837 |
| 74 | CSK | 0.68349191 |
| 75 | PAK2 | 0.68062491 |
| 76 | RET | 0.66693944 |
| 77 | LATS2 | 0.66454036 |
| 78 | STK24 | 0.65914047 |
| 79 | GRK1 | 0.63912153 |
| 80 | RPS6KA2 | 0.63442752 |
| 81 | ARAF | 0.63387894 |
| 82 | LRRK2 | 0.62134206 |
| 83 | MAP2K7 | 0.62073013 |
| 84 | MAP2K1 | 0.61882403 |
| 85 | CAMK4 | 0.59701935 |
| 86 | STK10 | 0.59555659 |
| 87 | MTOR | 0.59546474 |
| 88 | PRKCE | 0.59325716 |
| 89 | ABL2 | 0.59137103 |
| 90 | TBK1 | 0.58964291 |
| 91 | MARK2 | 0.57922628 |
| 92 | PDPK1 | 0.57786963 |
| 93 | EGFR | 0.56369888 |
| 94 | FLT3 | 0.56351888 |
| 95 | PLK2 | 0.55182970 |
| 96 | BMX | 0.54500854 |
| 97 | INSR | 0.53011173 |
| 98 | MARK1 | 0.52861074 |
| 99 | MAP3K14 | 0.52832470 |
| 100 | ERBB3 | 0.52590062 |
| 101 | ILK | 0.52571126 |
| 102 | PIM2 | 0.51112115 |
| 103 | EPHB1 | 0.50090490 |
| 104 | PAK4 | 0.49823245 |
| 105 | BCKDK | 0.49146134 |
| 106 | MAPK7 | 0.48778883 |
| 107 | STK39 | 0.48244829 |
| 108 | SGK3 | 0.47876973 |
| 109 | SIK3 | 0.46809662 |
| 110 | STK38L | 0.46675379 |
| 111 | JAK2 | 0.46564165 |
| 112 | SRC | 0.45995920 |
| 113 | MAPKAPK3 | 0.42798299 |
| 114 | NTRK1 | 0.39376479 |
| 115 | FGFR1 | 0.38881952 |
| 116 | CDK8 | 0.38480867 |
| 117 | CDK6 | 0.38349131 |
| 118 | PRKD2 | 0.37972435 |
| 119 | CAMK2D | 0.37475166 |
| 120 | PRKG2 | 0.37401195 |
| 121 | SGK2 | 0.36433908 |
| 122 | CAMK2G | 0.35429771 |
| 123 | TRIM28 | 0.34967569 |
| 124 | MAP3K12 | 0.34513739 |
| 125 | ABL1 | 0.34406017 |
| 126 | PRKCQ | 0.34039460 |
| 127 | MELK | 0.32763092 |
| 128 | ITK | 0.32641891 |
| 129 | ADRBK1 | 0.30901550 |
| 130 | MARK3 | 0.30133929 |
| 131 | TEC | 0.29664467 |
| 132 | GRK5 | 0.29493746 |
| 133 | TAOK2 | 0.29271984 |
| 134 | HCK | 0.28991031 |
| 135 | MET | 0.28641512 |
| 136 | FGR | 0.28467222 |
| 137 | CSNK1A1L | 0.23505371 |
| 138 | CAMK2B | 0.22701972 |
| 139 | ZAP70 | 0.20511169 |
| 140 | CLK1 | 0.20391721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.61858961 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.40206307 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.36154858 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.21051711 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.18008370 |
| 6 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.04566607 |
| 7 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.01432523 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.99705346 |
| 9 | Focal adhesion_Homo sapiens_hsa04510 | 1.95822125 |
| 10 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.81605268 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.76217640 |
| 12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.73634770 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.68754766 |
| 14 | Adherens junction_Homo sapiens_hsa04520 | 1.67435593 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.66079913 |
| 16 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.65993534 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.60007192 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.52311394 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.49502995 |
| 20 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.43827831 |
| 21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.42205130 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.41329963 |
| 23 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.39654936 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.38845867 |
| 25 | Amoebiasis_Homo sapiens_hsa05146 | 1.36631691 |
| 26 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.34962225 |
| 27 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.33473870 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.33246137 |
| 29 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.30155756 |
| 30 | Bladder cancer_Homo sapiens_hsa05219 | 1.29672338 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.29483853 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.25823576 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.22146316 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.18472952 |
| 35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.11249908 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10665400 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10463876 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.09789762 |
| 39 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.04993322 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.04305376 |
| 41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03344949 |
| 42 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.02983832 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02411469 |
| 44 | Insulin resistance_Homo sapiens_hsa04931 | 1.00017100 |
| 45 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.99869374 |
| 46 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.99593506 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.99369338 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 0.98571397 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.97638226 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96908849 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96070575 |
| 52 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.93009056 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89801952 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89135135 |
| 55 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.88819181 |
| 56 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.88584140 |
| 57 | Peroxisome_Homo sapiens_hsa04146 | 0.87390088 |
| 58 | Pathways in cancer_Homo sapiens_hsa05200 | 0.86532838 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.86261293 |
| 60 | Endocytosis_Homo sapiens_hsa04144 | 0.85285544 |
| 61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.84689830 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84368923 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84271201 |
| 64 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.81195116 |
| 65 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.81187232 |
| 66 | * Axon guidance_Homo sapiens_hsa04360 | 0.81109858 |
| 67 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.80771649 |
| 68 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80222259 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.79145804 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.79065452 |
| 71 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78225729 |
| 72 | Melanoma_Homo sapiens_hsa05218 | 0.78023219 |
| 73 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77347910 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76773458 |
| 75 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74920245 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.74080000 |
| 77 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.73832770 |
| 78 | Renin secretion_Homo sapiens_hsa04924 | 0.72820755 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72616291 |
| 80 | Lysine degradation_Homo sapiens_hsa00310 | 0.71225666 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70272348 |
| 82 | Tight junction_Homo sapiens_hsa04530 | 0.69826829 |
| 83 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69740316 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.69323296 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.69269453 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69153741 |
| 87 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68083230 |
| 88 | Pertussis_Homo sapiens_hsa05133 | 0.67996501 |
| 89 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67336542 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.65948640 |
| 91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65742136 |
| 92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64255688 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.63524538 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62597141 |
| 95 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.60102706 |
| 96 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58573622 |
| 97 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57536944 |
| 98 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57484569 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.57247639 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57228775 |
| 101 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.55505356 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53855960 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53090022 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52890139 |
| 105 | Retinol metabolism_Homo sapiens_hsa00830 | 0.52770430 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52583188 |
| 107 | Leishmaniasis_Homo sapiens_hsa05140 | 0.51359021 |
| 108 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50922029 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50896758 |
| 110 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50168876 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.48788053 |
| 112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48596019 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48101303 |
| 114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47599922 |
| 115 | Salmonella infection_Homo sapiens_hsa05132 | 0.47129444 |
| 116 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46544536 |
| 117 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46468350 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46398525 |
| 119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.45613737 |
| 120 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.45611610 |
| 121 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.45430190 |
| 122 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.45425787 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45255639 |
| 124 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.45039302 |
| 125 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44508386 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44055785 |
| 127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43433054 |
| 128 | Tuberculosis_Homo sapiens_hsa05152 | 0.43300293 |
| 129 | Gap junction_Homo sapiens_hsa04540 | 0.42813230 |
| 130 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.42504081 |
| 131 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.42329873 |
| 132 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.42100402 |
| 133 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41097083 |
| 134 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40964017 |
| 135 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40479145 |
| 136 | Prostate cancer_Homo sapiens_hsa05215 | 0.40328037 |
| 137 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39949713 |
| 138 | Apoptosis_Homo sapiens_hsa04210 | 0.39818676 |
| 139 | Melanogenesis_Homo sapiens_hsa04916 | 0.39795129 |
| 140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39590478 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39073987 |
| 142 | Carbon metabolism_Homo sapiens_hsa01200 | 0.38284913 |
| 143 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37739633 |
| 144 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37497006 |
| 145 | Hepatitis C_Homo sapiens_hsa05160 | 0.35893430 |
| 146 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35659868 |
| 147 | Hepatitis B_Homo sapiens_hsa05161 | 0.31324133 |
| 148 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31093795 |

